Park City Group, Inc. (including ReposiTrak) — Form 10-Q Summary
Reporting period: First quarter of fiscal 2018, the three months ended September 30, 2017; filed November 9, 2017. The filing is by Park City Group, Inc., not a standalone ReposiTrak filing. ReposiTrak is a wholly owned subsidiary and a source of revenue growth.
Business context
The company sells cloud-based supply-chain, e-commerce, and food-safety and compliance software. Its hub-and-spoke model generates most revenue from recurring supplier subscriptions, alongside professional services and occasional software licenses. The interim financial statements are unaudited.
Financial results and liquidity
| Metric | Quarter ended Sep. 30, 2017 | Prior-year quarter | Change |
|---|---|---|---|
| Revenue | $4.712 million | $4.217 million | +12% |
| Operating income | $414,000 | $680,000 | −39% |
| Net income | $331,000 | $614,000 | −46% |
| Net income applicable to common shareholders | $214,000 | $428,000 | −50% |
| Basic and diluted EPS | $0.01 | $0.02 | Down |
| Operating cash flow | $1.056 million provided | $122,000 used | Improved |
- Margins: Cost of services and product support was 30% of revenue versus 29% a year earlier, implying gross margins of approximately 70% and 71%, respectively. Operating margin declined to approximately 8.8% from 16.1%.
- Cash and working capital: Cash was $14.886 million at September 30, up from $14.054 million at June 30. Working capital was $11.346 million, up from $10.537 million. Current assets were $20.182 million and current liabilities $8.836 million.
- Debt: The balance sheet reports $2.850 million drawn on lines of credit and approximately $2.290 million in notes payable, or about $5.140 million total debt. The filing’s interest-rate breakdown is internally inconsistent; see verification items.
- Cash flows: Investing activities used $198,000, including $111,000 of capitalized software costs and $87,000 for property and equipment. Financing activities used $26,000. Cash increased $832,000 during the quarter.
Changes and management commentary
- Revenue growth was attributed primarily to ReposiTrak food-safety solutions. Management said service and support costs rose with new product introductions and employee costs; sales and marketing increased with sales-team expansion; and general and administrative costs rose with hosted software and professional fees for process automation and optimization.
- Despite revenue growth, operating income and net income declined as operating expenses grew faster than revenue. Sales and marketing expense rose 33% year over year.
- Management stated that cash, short-term investments, and operating cash generation should be sufficient for at least the next 12 months. Future capital needs depend on growth, sales and marketing, research and development, and product acceptance. No numerical earnings or revenue guidance was provided.
Outlook, risks, and unusual items
- Strategic review: After the quarter, the board directed management to engage a financial advisory firm to explore strategic options. The company gave no assurance about timing or outcome and said it did not intend to comment on developments absent an approved course of action or other disclosure obligation.
- Preferred stock and related party: Preferred shares carry dividends of 7% if paid in cash or 9% if paid in additional shares. In July 2017, 20,000 Series B-1 preferred shares were issued to Fields Management, Inc. in satisfaction of an accrued bonus for CEO Randall K. Fields, who controls FMI. The company reported $149,063 payable to FMI at quarter-end.
- Accounting and other risks: The company was assessing the impact of new revenue-recognition, stock-compensation, and lease standards. It reported no material pending or threatened legal proceeding, no additional risk factors beyond those in its fiscal 2017 Form 10-K, and no material off-balance-sheet arrangements. Management judged disclosure controls effective and reported no material change in internal control over financial reporting.
Most important facts for investors to verify
- Clarify the filing’s debt interest-rate disclosure: its narrative says 6.7% variable-rate and 93.3% fixed-rate debt, while the table labels $339,548 (7%) fixed and $4,800,257 (93%) variable—the percentages and labels conflict.
- Monitor the board’s strategic review for any announced transaction, change in strategy, or resulting financing implications.
- Assess whether ReposiTrak’s growth can continue while expense growth—particularly sales and marketing—outpaces revenue and pressures operating margins.
- Review the preferred-stock dividend terms, dilution exposure, and related-party arrangements, including the CEO bonus settlement and FMI payable.
- Track the company’s adoption assessments for new accounting standards and any effects on reported revenue, cash flows, or balance-sheet obligations.